Back
Lixte Biotechnology Holdings Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
LIXT
Lixte Biotechnology Holdings
Last Price:
1.78
Seasonality Move:
2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Lixte Biotechnology Holdings Price Quote
$1.78
+0.26 (+17.11%)
(Updated: November 22, 2024 at 1:00 PM ET)
Lixte Biotechnology Holdings Key Stats
Sell
18
Lixte Biotechnology Holdings (LIXT)
is a Sell
Day range:
$1.45 - $1.60
52-week range:
$1.31 - $4.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
27.7K
Avg. volume:
1.2M
1-year change:
-46.85%
Market cap:
$3.4M
Revenue:
$0
EPS:
$-1.73
How Much Does Lixte Biotechnology Holdings Make?
Data Unavailable
Is Lixte Biotechnology Holdings Growing As A Company?
Data Unavailable
Lixte Biotechnology Holdings Stock Price Performance
-
Did Lixte Biotechnology Holdings Stock Go Up Last Month?
Lixte Biotechnology Holdings share price went down by -20.83% last month -
Did LIXT's Share Price Rise Over The Last Year?
LIXT share price fell by -46.85% over the past 1 year
What Is Lixte Biotechnology Holdings 52-Week High & Low?
-
What Is Lixte Biotechnology Holdings’s 52-Week High Share Price?
Lixte Biotechnology Holdings has traded as high as $4.42 over the past 52 weeks -
What Is Lixte Biotechnology Holdings’s 52-Week Low Share Price?
Lixte Biotechnology Holdings has traded as low as $1.31 over the past 52 weeks
Lixte Biotechnology Holdings Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lixte Biotechnology Holdings?
-
How Much Debt Does Lixte Biotechnology Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lixte Biotechnology Holdings Have?
Cash and short term investments quarterly total is $1.6M -
What Is Lixte Biotechnology Holdings’s Book Value Per Share?
Book value per share is -0.95
Is Lixte Biotechnology Holdings Cash Flow Positive?
-
What Is LIXT Cash Flow From Operations?
Cash flow from operations (TTM) is -$3.5M -
What Is Lixte Biotechnology Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Lixte Biotechnology Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Lixte Biotechnology Holdings Return On Invested Capital
Data Unavailable
Lixte Biotechnology Holdings Earnings Date & Stock Price
-
What Is Lixte Biotechnology Holdings's Stock Price Today?
A single share of LIXT can be purchased today for 1.52 -
What Is Lixte Biotechnology Holdings’s Stock Symbol?
Lixte Biotechnology Holdings trades on the nasdaq under the ticker symbol: LIXT -
When Is Lixte Biotechnology Holdings’s Next Earnings Date?
The next quarterly earnings date for Lixte Biotechnology Holdings is scheduled on May 9, 2025 -
When Is LIXT's next ex-dividend date?
Lixte Biotechnology Holdings's next ex-dividend date is November 22, 2024 -
How To Buy Lixte Biotechnology Holdings Stock?
You can buy Lixte Biotechnology Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lixte Biotechnology Holdings Competitors
-
Who Are Lixte Biotechnology Holdings's Competitors?
Below is a list of companies who compete with Lixte Biotechnology Holdings or are related in some way:
Lixte Biotechnology Holdings Dividend Yield
-
What Is LIXT Dividend Yield?
Lixte Biotechnology Holdings’s dividend yield currently is 0% -
What Is Lixte Biotechnology Holdings’s Payout Ratio?
Lixte Biotechnology Holdings’s payout ratio is 0% -
When Did Lixte Biotechnology Holdings Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Lixte Biotechnology Holdings’s Dividend Per Share?
Lixte Biotechnology Holdings pays a dividend of $0.00 per share
Lixte Biotechnology Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |